Legal Representation
Attorney
Shannon Marie McKeon
USPTO Deadlines
Next Deadline
1139 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-09-13)
Due Date
September 13, 2028
Grace Period Ends
March 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
31 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 24, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Jun 24, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Jun 24, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 24, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 24, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jun 24, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Feb 12, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Sep 13, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Sep 13, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Aug 6, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Aug 5, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Jul 27, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Jul 26, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jul 8, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
Jul 8, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
May 3, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Mar 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Mar 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jan 27, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 26, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 20, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 19, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 19, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jul 28, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 28, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jul 28, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 27, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Apr 24, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for myeloprotection and anti-tumor effects; pharmaceutical preparations for reducing side effects of chemotherapy; pharmaceutical preparations for use in oncology, improving outcomes from chemotherapy, and treatment of cancer; therapeutic preparations for use in patients with cancer
First Use Anywhere:
20210300
First Use in Commerce:
20210300
Class 042
Pharmaceutical research and development; providing medical and scientific research information in the fields of oncology, pharmaceuticals, therapies, diseases, and disorders
First Use Anywhere:
20200800
First Use in Commerce:
20200800
Additional Information
Design Mark
The mark consists of the stylized font of "G1" to the left of a circular design consisting of two intersecting circles placed on top of the stylized font of "THERAPEUTICS".
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"